NASDAQ

Strata Critical Medical, Inc. - Class A (SRTA)

378 Thanks from members

Strata Critical Medical (SRTA) demonstrates strong revenue growth, raised 2026 guidance, and positive operating cash flow, though tempered by ongoing quarterly net losses and varied institutional sentiment.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →